Literature DB >> 17876548

An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation.

Norihito Watanabe1, Shinji Takashimizu, Yasuhiro Nishizaki, Seiichiro Kojima, Tatehiro Kagawa, Shohei Matsuzaki.   

Abstract

BACKGROUND: Sinusoidal endothelial fenestrae (SEF) regulate the sinusoidal circulation by altering their diameter and number. This study documented the effects of endothelin (ET) receptor antagonists on SEF and hepatic microcirculation.
METHODS: The portal pressure and hepatic tissue blood flow were measured with a hydromanometer and a laser Doppler blood flow meter, respectively. BQ-123 (ET(A) receptor antagonist) or BQ-788 (ET(B) receptor antagonist) was continuously infused into normal rats at the rate of 10 nmol/min for 10 min. The sinusoids were observed at 60 min after the infusion by scanning electron microscopy. The localization of ET-1 and ET(A) and ET(B) receptors was examined by the indirect immunoperoxidase method.
RESULTS: When BQ-123 was infused, the portal pressure gradually decreased with time, and it showed a significant reduction compared with the control groups. On the other hand, a decrease in portal pressure was not evident in the BQ-788-infused groups. Hepatic tissue blood flow was maintained at the value prior to the infusion in both groups. BQ-123 also caused a marked dilatation of the SEF. The diameters of the SEF after BQ-123 infusion were almost three times those of normal SEF. ET-1 was evenly present along the sinusoidal walls, and the reaction products of the ET(A) receptors were recognized along the portal vein and in the sinusoidal cells, that is, the hepatic stellate cells and endothelial cells.
CONCLUSIONS: Action of ET-1 via the ET(A) receptors may regulate the size of SEF in addition to hepatic microcirculation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876548     DOI: 10.1007/s00535-007-2093-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  33 in total

Review 1.  Molecular characterization of endothelin receptors.

Authors:  T Sakurai; M Yanagisawa; T Masaki
Journal:  Trends Pharmacol Sci       Date:  1992-03       Impact factor: 14.819

2.  Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.

Authors:  H Yokomori; M Oda; M Ogi; Y Kamegaya; N Tsukada; M Nakamura; H Ishii
Journal:  Liver       Date:  2001-04

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.

Authors:  T Fukuroda; S Ozaki; M Ihara; K Ishikawa; M Yano; T Miyauchi; S Ishikawa; M Onizuka; K Goto; M Nishikibe
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Mechanisms and pathophysiological implications of sinusoidal endothelial cell gap formation following treatment with galactosamine/endotoxin in mice.

Authors:  Yoshiya Ito; Edward R Abril; Nancy W Bethea; Margaret K McCuskey; Cathleen Cover; Hartmut Jaeschke; Robert S McCuskey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-03-30       Impact factor: 4.052

6.  Endothelin-1 induces direct constriction of hepatic sinusoids.

Authors:  J X Zhang; W Pegoli; M G Clemens
Journal:  Am J Physiol       Date:  1994-04

7.  Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome.

Authors:  K Moore; J Wendon; M Frazer; J Karani; R Williams; K Badr
Journal:  N Engl J Med       Date:  1992-12-17       Impact factor: 91.245

8.  Endothelin association with the cultured rat Kupffer cell: characterization and regulation.

Authors:  K Stephenson; S A Harvey; S B Mustafa; A T Eakes; M S Olson
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

9.  Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.

Authors:  T K Gupta; M Toruner; M K Chung; R J Groszmann
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

View more
  7 in total

1.  Endothelin-1 receptor A blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats.

Authors:  Ralf Bahde; Sorabh Kapoor; Preeti Viswanathan; Hans-Ullrich Spiegel; Sanjeev Gupta
Journal:  Hepatology       Date:  2014-01-16       Impact factor: 17.425

2.  Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.

Authors:  Devaraj Ezhilarasan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-13

Review 3.  A Sieve-Raft Hypothesis for the regulation of endothelial fenestrations.

Authors:  Victoria C Cogger; Ute Roessner; Alessandra Warren; Robin Fraser; David G Le Couteur
Journal:  Comput Struct Biotechnol J       Date:  2013-08-24       Impact factor: 7.271

4.  Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injury.

Authors:  Arya J Bahrami; Jagadambika J Gunaje; Brian J Hayes; Kimberly J Riehle; Heidi L Kenerson; Raymond S Yeung; April S Stempien-Otero; Jean S Campbell; William M Mahoney
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

5.  Novel treatment options for portal hypertension.

Authors:  Philipp Schwabl; Wim Laleman
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-18

Review 6.  Advances in therapeutic options for portal hypertension.

Authors:  Marina Vilaseca; Sergi Guixé-Muntet; Anabel Fernández-Iglesias; Jordi Gracia-Sancho
Journal:  Therap Adv Gastroenterol       Date:  2018-11-25       Impact factor: 4.409

7.  Beetle (Ulomoides dermestoides) fat improves diabetes: effect on liver and pancreatic architecture and on PPARγ expression.

Authors:  E I Jasso-Villagomez; M Garcia-Lorenzana; J C Almanza-Perez; M A Fortis-Barrera; G Blancas-Flores; R Roman-Ramos; L A Prado-Barragan; F J Alarcon-Aguilar
Journal:  Braz J Med Biol Res       Date:  2018-04-19       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.